You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY22 is not expected to be complete until September, 2023.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
-
SURGICAL REAMER CUTTER
SBC: BIOENGINEERING CONSULTANTS, LTD Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
CONTROLLABLE MINIATURE CHOLANGIOSCOPE
SBC: BIOENGINEERING CONSULTANTS, LTD Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
COST EFFECTIVE MANAGEMENT OF CARDIAC REHAB ON
SBC: Biomedical Development Corporation Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
NOVEL EXTERNAL URINARY COLLECTION SYSTEM
SBC: Biomedical Development Corporation Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
TREATMENT FOR GBS COLONIZATION IN PREGNANT WOMEN
SBC: Biomedical Development Corporation Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
NOVEL SKIN PORT DEVICE FOR BLOOD GLUCOSE SENSING
SBC: Biotex, Inc. Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
DETECTION OF ANALYTES SECRETED FROM SINGLE CELLS
SBC: BIOTRACES, INC. Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
ULTRASENSITIVE DETECTION OF PROSTATE CANCER
SBC: BIOTRACES, INC. Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
SYSTEM FOR SCREENING BLOOD DONORS WITH PCR-BASED ASSAYS
SBC: Cenetron Diagnostics, Llc Topic: N/ADESCRIPTION: CMV is a major source of morbidity and mortality in immunocompromised individuals. This virus is responsible for a range of clinically apparent syndromes, ranging from sight-threatening retinitis in AIDS patients to life-threatening pneumonia in bone marrow and renal allograft transplant recipients. In the U.S. alone, over 4 billion dollars of health care costs are incurred as a conse ...
SBIR Phase I 1997 Department of Health and Human Services -
RECOMBINANT ANTIBODIES AS INTRA VAGINAL SPERMICIDES
SBC: CONTRAVAC, INC. Topic: N/AWorld population is predicted to reach 10 billion people by the year 2050, increasing more than 75% over the current population. Development of new contraceptive options is necessary to provide accessible birth control to all individuals regardless of sociological, financial, or educational limitations. Current literature implicates marketed spermicidal formulations in cervical and vaginal irritat ...
SBIR Phase I 1997 Department of Health and Human Services